Patents by Inventor Endre Bakken Stovner

Endre Bakken Stovner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20210363525
    Abstract: The invention relates to oligonucleotides, e.g., saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising such oligonucleotides. Methods of making and using the oligonucleotides and the therapeutic compositions are also provided.
    Type: Application
    Filed: May 13, 2021
    Publication date: November 25, 2021
    Inventors: Pål Sætrom, Endre Bakken Stovner
  • C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20210187007
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: December 9, 2020
    Publication date: June 24, 2021
    Inventors: Andreas Wagner, Robert Habib, Hans E. Huber, Pål Saetrom, Endre Bakken Stovner, Markus Hossbach, Monika Krampert, Hans-Peter Vornlocher
  • C/EBP alpha saRNA compositions and methods of use
    Patent number: 10912790
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: February 9, 2021
    Assignee: MiNA THERAPEUTICS LIMITED
    Inventors: Andreas Wagner, Robert Habib, Hans E. Huber, Pål Sætrom, Endre Bakken Stovner, Markus Hossbach, Monika Krampert, Hans-Peter Vornlocher
  • C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20200376020
    Abstract: The invention relates to saRNA targeting a C/EBP? transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: April 21, 2016
    Publication date: December 3, 2020
    Applicant: MiNA THERAPEUTICS LIMITED
    Inventors: Andreas Wagner, Robert Habib, Hans E. Huber, Pål Sætrom, Endre Bakken Stovner, Markus Hossbach, Monika Krampert, Hans-Peter Vornlocher
  • SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20180305689
    Abstract: The invention relates to oligonucleotides, e.g., saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising such oligonucleotides. Methods of using the oligonucleotides and the therapeutic compositions are also provided.
    Type: Application
    Filed: April 21, 2016
    Publication date: October 25, 2018
    Inventors: Pål Sætrom, Endre Bakken Stovner
  • SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20180258429
    Abstract: The invention relates to a saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Inventors: Pål Sætrom, Endre Bakken Stovner
  • SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20170044540
    Abstract: The invention relates to a saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.
    Type: Application
    Filed: April 22, 2015
    Publication date: February 16, 2017
    Applicant: MINA THERAPEUTICS LIMITED
    Inventors: Pål Sætrom, Endre Bakken Stovner